GS-5319 / Gilead - LARVOL DELTA

Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors (clinicaltrials.gov) - P1 | N=476 | Recruiting | Sponsor: Gilead Sciences | N=178 ➔ 476

Enrollment change • Monotherapy • Oncology • Solid Tumor • MTAP

GS-US-707-7297: Study of GS-5319 in Adults With Solid Tumors (clinicaltrialsregister.eu) - P1 | N=35 | Recruiting | Sponsor: Gilead Sciences Inc.

New P1 trial • Oncology • Solid Tumor